Responses
Abstracts
Presentations on Thursday, March 22nd, 8:30 - 10:00, Amber 11
TCH034 Proteomic approach to investigating the molecular integrity of infliximab after reconstitution and dilution in typical hospital conditions
Compose a Response to This Article
Other responses
No responses have been published for this article.